Effect of dextran infusion and state of hydration on cerebral toxicity of angiographic contrast media
Doust, B.D.; Fischer, H.W.
Investigative Radiology 6(5): 354-355
1971
ISSN/ISBN: 0020-9996 DOI: 10.1097/00004424-197109000-00057
Accession: 026466646
PDF emailed within 0-6 h: $19.90
Related References
Doust, B.D.; Fischer, H.W. 1972: The effects of dextran infusion, glucose infusion, and state of hydration on cerebral toxicity of arteriographic contrast media Radiology 103(3): 607-609Lagemann, K. 1975: The pharmaco-kinetics of angiographic contrast media with special reference to the extra-vascular spaces. Fundamental studies on dog for the characterisation of angiographic media. I The pharmaco-kinetics of various contrast media under conditions of constant infusion (balanced flow) Rofo: Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 123(3): 247-252
Lageman, K. 1975: The pharmaco kinetics of angiographic contrast media with special reference to the extravascular spaces fundamental studies on dogs for the characterization of angiographic media part 1 the pharmaco kinetics of various contrast media under conditions of constant infusion balanced flow Fortschritte auf dem Gebiete der Roentgenstrahlen und der Nuklearmedizin 123(3): 247-252
Zsebok, Z.B.; Szlavy, L. 1970: On the problem of toxicity in angiographic contrast media Internationale Zeitschrift fuer Klinische Pharmakologie Therapie und Toxikologie 3(2): 157-162
Foster, J.H.; Killen, D.A.; Sessions, R.T.; Rhea, G.W.; Winfrey, E.W.; Collins, H.A. 1964: The Relative Toxicity of Angiographic Contrast Media Vascular Diseases 1: 8-20
Lagemann, K. 1976: The pharmaco-kinetics of angiographic contrast media with special reference to the extravascular space. Experimental studies on dogs. III. Is there an entero-hepatic circulation of angiographic contrast media? A discussion summarising the results of the entire studies Rofo: Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 124(1): 69-75
Broadbridge, A.T.; Leslie, E.V. 1958: Cerebral angiographic contrast media; a comparison of hypaque 45% and urografin 60% and an assessment of the relative clinical toxicity of urografin 60%, hypaque 45%, diaginol 25% and diodone 35% in carotid arteriography British Journal of Radiology 31(370): 556-560
Zsebök, Z.B.; Szlávy, L. 1970: Toxicity problems with respect to angiographic contrast media Internationale Zeitschrift für Klinische Pharmakologie Therapie und Toxikologie. International Journal of Clinical Pharmacology Therapy and Toxicology 3(2): 157-162
Hilal, S.K. 1966: Hemodynamic responses in the cerebral vessels to angiographic contrast media Acta Radiologica: Diagnosis 5: 211-231
Fischer, H.W.; Redman, H.C.; Doust, B.D. 1970: Factors in toxicity of cerebral angiographic media Investigative Radiology 5(4): 290
Kishimoto, M.; Yamada, K.; Tsuneda, R.; Shimizu, J.; Iwasaki, T.; Miyake, Y-Ichi. 2008: Effect of contrast media formulation on computed tomography angiographic contrast enhancement Veterinary Radiology and Ultrasound: the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association 49(3): 233-237
Fischer, H.W.; Eckstein, J.W. 1961: Comparison of cerebral angiographic contrast media by their circulatory effects; an experimental study American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine 86: 166-177
Herrschaft, H.; Gleim, F.; Schmidt, H. 1974: Effects of angiographic contrast media on regional cerebral blood flow and haemodynamics in man Neuroradiology 7(2): 95-103
Simonetti, G.; Fanucci, E.; Bortolotti, L. 1995: Current state and prospects of the use of uro-angiographic, ultrasonographic and magnetic resonance contrast media La Radiologia Medica 90(5): 670-674
Robert, F. 1969: The influence of the contrast media on the collateral circulation at the closure of the middle cerebral artery. An angiographic examination Radiologia Clinica et Biologica 38(6): 357-371